Lineage Cell Therapeutics, Inc.
LCTX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000876343
No open-market purchases or sales by Lineage Cell Therapeutics, Inc. insiders were filed in the last 90 days; 131 institutions reported holding it in 13F filings for Q2 2026, worth $152.7M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Lineage Cell Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 116
- +12 vs. Q4 2022
- Shares held
- 69.7M
- +4.56M (+7.0%) vs. Q4 2022
- Total value
- $104.7M
- +$28.5M (+37.3%) vs. Q4 2022
- New holders
- 24
- 26 more added
- Sold out
- 12
- 21 more reduced
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 131 | $152.7M |
| Q1 2026 | 130 | $176.5M |
| Q4 2025 | 123 | $169.8M |
| Q3 2025 | 112 | $148.6M |
| Q2 2025 | 129 | $88.4M |
| Q1 2025 | 127 | $49.7M |
| Q4 2024 | 126 | $53.8M |
| Q3 2024 | 114 | $85.6M |
| Q2 2024 | 113 | $94.2M |
| Q1 2024 | 116 | $138.3M |
| Q4 2023 | 115 | $82.5M |
| Q3 2023 | 104 | $89.1M |
| Q2 2023 | 107 | $106.6M |
| Q1 2023 | 116 | $104.7M |
| Q4 2022 | 106 | $76.2M |
| Q3 2022 | 104 | $73.1M |
| Q2 2022 | 100 | $102.7M |
| Q1 2022 | 109 | $112.3M |
| Q4 2021 | 124 | $182.0M |
| Q3 2021 | 115 | $191.7M |
| Q2 2021 | 115 | $208.5M |
| Q1 2021 | 102 | $141.8M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Lineage Cell Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State Street Corp | 437,496 | $656.2K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 462,884 | $694.3K | 0.00% | −14,290−3.0% | Reduced |
| Jane Street Group, LLC | 596,444 | $894.7K | 0.00% | +455,199+322.3% | Added |
| Bridgeway Capital Management, LLC | 781,766 | $1.17M | 0.03% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 816,387 | $1.22M | 0.00% | +642,768+370.2% | Added |
| JPMorgan Chase & Co | 1,112,111 | $1.67M | 0.00% | +23,532+2.2% | Added |
| Geode Capital Management, LLC | 1,282,000 | $1.92M | 0.00% | +17,591+1.4% | Added |
| Millennium Management LLC | 1,402,123 | $2.10M | 0.00% | +1,003,084+251.4% | Added |
| Bank of America Corp | 1,443,779 | $2.17M | 0.00% | +1,442,750+140,208.9% | Added |
| Raffles Associates LP | 1,536,946 | $2.31M | 3.14% | 00.0% | Unchanged |
| Prescott General Partners LLC | 1,851,851 | $2.78M | 0.22% | 00.0% | Unchanged |
| Laurion Capital Management LP | 2,377,940 | $3.57M | 0.16% | 00.0% | Unchanged |
| BlackRock Inc. | 3,709,578 | $5.56M | 0.00% | −74,234−2.0% | Reduced |
| Defender Capital, LLC. | 5,136,085 | $7.70M | 2.69% | +42,550+0.8% | Added |
| Vanguard Group Inc | 6,504,938 | $9.76M | 0.00% | +397,884+6.5% | Added |
| Broadwood Capital Inc | 34,935,485 | $52.4M | 3.69% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −202,202−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −187,789−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −74,065−100.0% | Sold out |
| Phoenix Holdings Ltd. | 0 | $0 | 0.00% | −48,716−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −29,406−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −10,400−100.0% | Sold out |
| Integrated Wealth Concepts LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −162−100.0% | Sold out |
| Coppell Advisory Solutions Corp. | 0 | $0 | 0.00% | −162−100.0% | Sold out |
| 1832 Asset Management L.P. | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −280−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Trustcore Financial Services, LLC | – | – | – | – | Not filed |
| Cribstone Capital Management, LLC | – | – | – | – | Not filed |